Published in Crit Care Med on August 01, 2004
Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med (2013) 1.94
Septic cardiomyopathy - A not yet discovered cardiomyopathy? Exp Clin Cardiol (2006) 1.36
Endotoxin elimination in sepsis: physiology and therapeutic application. Langenbecks Arch Surg (2010) 1.12
Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect. Toxins (Basel) (2013) 0.98
Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge. Mediators Inflamm (2013) 0.86
Sepsis and septic shock. Nat Rev Dis Prim (2016) 0.85
Alteco endotoxin hemoadsorption in Gram-negative septic shock patients. Indian J Crit Care Med (2014) 0.82
Residual rates of mortality in patients with severe sepsis: a fatality or a new challenge? Ann Intensive Care (2013) 0.78
Scanning the horizon: emerging hospital-wide technologies and their impact on critical care. Crit Care (2005) 0.76
Extracorporeal endotoxin adsorption in septic patients--does it work? Crit Care Med (2004) 0.75
Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis. Crit Care Med (2005) 0.75
Sepsis and Septic Shock: Current Treatment Strategies and New Approaches. Eurasian J Med (2017) 0.75
Management and Novel Adjuncts of Necrotizing Soft Tissue Infections. Surg Infect (Larchmt) (2017) 0.75
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
Anemia and blood transfusion in critically ill patients. JAMA (2002) 7.83
Trial of the route of early nutritional support in critically ill adults. N Engl J Med (2014) 7.06
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med (2007) 4.99
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA (2003) 4.54
Prognostic value of extravascular lung water in critically ill patients. Chest (2002) 4.46
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med (2004) 4.24
Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis (2012) 4.07
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med (2005) 3.85
Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med (2012) 3.39
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37
The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med (2012) 3.18
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med (2015) 2.81
An outbreak in an intensive care unit of a strain of methicillin-resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. Clin Infect Dis (2007) 2.64
Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med (2002) 2.61
High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med (2003) 2.43
Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med (2004) 2.15
Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med (2009) 1.83
A controlled trial of electronic automated advisory vital signs monitoring in general hospital wards. Crit Care Med (2012) 1.63
The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med (2015) 1.55
Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX). Crit Care Med (2015) 1.40
How to increase return on investment of the intensive care pharmacist - fear of flying. Intensive Care Med (2006) 1.39
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med (2014) 1.38
Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock (2002) 1.35
Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest (2002) 1.28
The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. Crit Care (2009) 1.22
Genome-wide sequencing of cellular microRNAs identifies a combinatorial expression signature diagnostic of sepsis. PLoS One (2013) 1.15
Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res (2007) 1.11
Low and "supranormal" central venous oxygen saturation and markers of tissue hypoxia in cardiac surgery patients: a prospective observational study. Intensive Care Med (2010) 1.10
Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration. Chemotherapy (2003) 1.06
Physiological predictors of survival during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care (2013) 0.95
Continuous monitoring of ScvO(2) by a new fibre-optic technology compared with blood gas oximetry in critically ill patients: a multicentre study. Intensive Care Med (2007) 0.91
Supplementation of omega-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern. JPEN J Parenter Enteral Nutr (2007) 0.91
The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Med Oncol (2006) 0.90
Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care (2003) 0.88
Amino acid imbalance early in septic encephalopathy. Intensive Care Med (2002) 0.87
A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE adsorber. Transfus Apher Sci (2003) 0.85
Cost analysis of parenteral nutrition regimens in the intensive care unit: three-compartment bag system vs multibottle system. JPEN J Parenter Enteral Nutr (2008) 0.85
Measurement of indocyanine green plasma disappearance rate by two different dosages. Intensive Care Med (2004) 0.85
Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study. Crit Care (2011) 0.84
Pitfalls in haemodynamic monitoring based on the arterial pressure waveform. Crit Care (2010) 0.83
Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy. Crit Care (2008) 0.82
Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis. Intensive Care Med (2015) 0.80
[Fat emulsions in parenteral feeding: the present and the future perspectives]. Wien Klin Wochenschr (2003) 0.80
Retrospective analysis of outcome of women with breast or gynaecological cancer in the intensive care unit. JRSM Short Rep (2013) 0.79
Risk factors for acute organ failure in intensive care unit patients who receive respiratory support in the absence of non-respiratory organ failure: an international prospective cohort study. Crit Care (2012) 0.79
Depletion of blood neutrophils from patients with sepsis: treatment for the future? Int Immunopharmacol (2013) 0.79
Stent-based approach for ventricle-to-coronary artery bypass. Circulation (2002) 0.79
Extravascular lung water in acute respiratory distress syndrome: potential clinical value, assumptions and limitations. Crit Care (2012) 0.78
Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use? Wien Klin Wochenschr (2011) 0.78
Searching biomarker candidates in serum using multidimensional native chromatography. II Method evaluation with Alport syndrome and severe inflammation. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.78
An assessment of algorithms to estimate respiratory rate from the electrocardiogram and photoplethysmogram. Physiol Meas (2016) 0.77
Echoes of the past? Crit Care Med (2008) 0.77
Moderate-dose vasopressin therapy may impair gastric mucosal perfusion in severe sepsis: a pilot study. Anesthesiology (2011) 0.77
Industry-sponsored economic studies in critical and intensive care versus studies sponsored by nonprofit organizations. J Intensive Care Med (2004) 0.77
Assessment of regional lung mechanics with electrical impedance tomography can determine the requirement for ECMO in patients with severe ARDS. Intensive Care Med (2012) 0.77
A life-threatening sore throat masquerading as swine flu. Lancet (2010) 0.76
Ventilatory support versus ECMO for severe adult respiratory failure. Lancet (2010) 0.75
Are we ready for MEDS in the ED? Crit Care Med (2007) 0.75
Bleeding diathesis due to failed antagonism of heparin: successful treatment with recombinant factor VIIa. Anesth Analg (2004) 0.75
Activation-Associated Accelerated Apoptosis of Memory B Cells in Critically Ill Patients With Sepsis. Crit Care Med (2017) 0.75
Contact dermatitis to levobunolol eyedrops superimposed on IgE-mediated rhinoconjunctivitis. Ann Allergy Asthma Immunol (2006) 0.75
Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients. Exp Toxicol Pathol (2003) 0.75
Maintaining normal levels of ionized calcium during citrate-based renal replacement therapy is associated with stable parathyroid hormone levels. Nephron Clin Pract (2013) 0.75
Extraction of respiratory signals from the electrocardiogram and photoplethysmogram: technical and physiological determinants. Physiol Meas (2017) 0.75
[Arginine-vasopressin in septic and vasodilatorial shock]. Anasthesiol Intensivmed Notfallmed Schmerzther (2006) 0.75
Creatinine measurements by the Jaffé method in different peritoneal dialysis fluids exhibit wide variation. Perit Dial Int (2006) 0.75
Unless high-quality clinical data show they are safe, synthetic colloids should not be used in patients with head injury. Intensive Care Med (2012) 0.75
Discordant response to ACTH stimulation in patients with septic shock. Intensive Care Med (2006) 0.75
Optimising the Windkessel model for cardiac output monitoring during changes in vascular tone. Conf Proc IEEE Eng Med Biol Soc (2014) 0.75